Literature DB >> 29362983

Detrimental effects of nitroglycerin use during regadenoson vasodilator stress testing: A cautionary tale.

Vineet Agrawal1, Carolann Hosey2,3, Gary T Smith4,5, Chirayu Shah4,5.   

Abstract

Vasodilator agents such as adenosine and regadenoson are commonly used pharmacologic stressors to assess for ischemia in patients undergoing myocardial perfusion studies. The recommended reversal agent for this mode of stress is aminophylline, although nitroglycerin is commonly administered as an attempt to reverse the symptoms or electrocardiographic (EKG) changes during the stress test. We demonstrate through two cases that incorrect administration of nitroglycerin can induce hypotension and worsen coronary steal, whereas appropriate administration of aminophylline can reverse the effects of pharmacologic vasodilators. While nitroglycerin is often used in patients with organic angina, it has the potential to worsen ischemia in the setting of pharmacologic vasodilator administration. These cases underscore the importance of administering the correct reversal agent for pharmacologic stress tests.

Entities:  

Keywords:  Myocardial perfusion imaging: SPECT; acute coronary syndromes; pharmacologic stress; unstable angina; vasodilator stress

Mesh:

Substances:

Year:  2018        PMID: 29362983     DOI: 10.1007/s12350-017-1174-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  4 in total

Review 1.  The nitrovasodilators. New ideas about old drugs.

Authors:  D G Harrison; J N Bates
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

2.  Effect of nitroglycerin and dipyridamole on regional left ventricular blood flow during coronary artery occlusion.

Authors:  L C Becker
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

3.  The use of the acute Pd/Pa drop after intracoronary nitroglycerin infusion to rule out significant FFR: CANICA (Can intracoronary nitroglycerin predict fractional flow reserve without adenosine?) multicenter study.

Authors:  R Martin-Reyes; J M de la Torre Hernandez; J Franco-Pelaez; R Lopez-Palop; M Telleria Arrieta; I J Amat Santos; P Carrillo Saez; A Sanchez-Recalde; J C Sanmartin Pena; T Garcia Camarero; S Brugaletta; F Gimeno de Carlos; A Pinero; D C Sorto Sanchez; A Frutos; G Lasa Larraya; F Navarro; J Farre
Journal:  Catheter Cardiovasc Interv       Date:  2015-07-25       Impact factor: 2.692

4.  Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs: potential for use in myocardial perfusion imaging.

Authors:  Jean-Noël Trochu; Gong Zhao; Heiner Post; Xiaobin Xu; Luiz Belardinelli; Francis L Belloni; Thomas H Hintze
Journal:  J Cardiovasc Pharmacol       Date:  2003-01       Impact factor: 3.105

  4 in total
  1 in total

1.  Adverse effects associated with regadenoson myocardial perfusion imaging.

Authors:  Efstathia Andrikopoulou; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2018-02-21       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.